Bryan Johnson, the tech entrepreneur known for his high-profile efforts to slow aging, says he is questioning whether he may have taken his “longevity” experiment too far. Multiple reports describe his comments as coming weeks after he received a diagnosis related to an autoimmune condition. According to NDTV and Mint, Johnson’s assessment follows the news of an autoimmune disease diagnosis, with Mint specifying autoimmune gastritis. Business Insider similarly frames his remarks as doubts about the broader “longevity thing,” describing him as reflecting on potential consequences of his long-running regimen.
The coverage is broadly aligned on the same core development: Johnson expresses concern that the health interventions, lifestyle changes, or medical approach he has used in pursuit of longevity may have led to unintended effects. While the reports vary slightly in phrasing and in how specific they are about the diagnosis, they converge on the idea that his latest statement is prompted by health concerns arising after the diagnosis. None of the sources dispute that he has invested significant time and resources in longevity-focused practices, but they present his recent comments as a shift toward self-critique.
